Kato, Kelly C

Efficacy of Meglumine Antimoniate in a Low Polymerization State Orally Administered in a Murine Model of Visceral Leishmaniasis. [electronic resource] - Antimicrobial agents and chemotherapy 08 2018

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1098-6596

10.1128/AAC.00539-18 doi


Administration, Oral
Animals
Caco-2 Cells
Disease Models, Animal
Female
Humans
Leishmaniasis, Visceral--drug therapy
Meglumine Antimoniate--administration & dosage
Mice
Mice, Inbred BALB C
Polymerization